These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2310656)

  • 1. Acute haemodynamic effects of cromakalim in patients with angina pectoris.
    Thomas P; Dixon MS; Winterton SJ; Sheridan DJ
    Br J Clin Pharmacol; 1990 Mar; 29(3):325-31. PubMed ID: 2310656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
    Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary and systemic haemodynamic effects of cromakalim in conditions of normoxia and hypoxia in dogs.
    Martin DJ; Gellotte M; Armstrong JM; Hicks PE
    J Auton Pharmacol; 1990 Oct; 10(5):261-72. PubMed ID: 2084109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels.
    Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.
    D'Alonzo AJ; Grover GJ; Darbenzio RB; Sewter JC; Hess TA; Dzwonczyk S; Sleph PG
    Pharmacology; 1996 Feb; 52(2):101-12. PubMed ID: 8851631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
    Giudicelli JF; la Rochelle CD; Berdeaux A
    J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cromakalim does not protect against skeletal muscle fatigue in an anaesthetized rat model of acute hindlimb ischaemia.
    Trezise DJ; Drew GM; Roach AG; Watts IS; Weston AH
    Eur J Pharmacol; 1993 Nov; 250(1):109-16. PubMed ID: 8119308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity of BMS-180448 on myocardial versus brain blood flow in dogs and ferrets.
    Weselcouch EO; Gomoll AW
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):61-8. PubMed ID: 9268222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The haemodynamic profile of cromakalim in the cat.
    Clapham JC; Buckingham RE
    J Cardiovasc Pharmacol; 1988; 12(5):555-61. PubMed ID: 2468055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the haemodynamic profiles of Ro 31-6930, cromakalim and nifedipine in anaesthetised normotensive rats.
    Duty S; Paciorek PM; Waterfall JF; Weston AH
    Eur J Pharmacol; 1990 Aug; 185(1):35-42. PubMed ID: 2226633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potassium agonists: regional vasodilator profile in rats].
    Richer C; Mulder P; Doussau MP; Giudicelli JF
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1333-7. PubMed ID: 2510669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical pharmacology of Ro 31-6930, a new potassium channel opener.
    Paciorek PM; Burden DT; Burke YM; Cowlrick IS; Perkins RS; Taylor JC; Waterfall JF
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):188-97. PubMed ID: 1689412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of molsidomine in patients with severe chronic coronary disease.
    Crexells C; Lidón RM; Augé JM; Bosch X; Pina C; Garcia J; Oriol A
    Eur Heart J; 1985 Dec; 6(12):1032-9. PubMed ID: 3841658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic profile of the potassium channel activator EMD 52692 in anaesthetized pigs.
    Sassen LM; Duncker DJ; Gho BC; Diekmann HW; Verdouw PD
    Br J Pharmacol; 1990 Nov; 101(3):605-14. PubMed ID: 2076480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Part I: pharmacologic and hemodynamic actions and interactions. Pharmacologic and hemodynamic mechanisms underlying the antianginal actions of verapamil.
    Singh BN; Chew CY; Josephson MA; Packer M
    Am J Cardiol; 1982 Oct; 50(4):886-93. PubMed ID: 6751064
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.
    Silke B; Verma SP; Zezulka AV; Sharma S; Reynolds G; Jackson NC; Guy S; Taylor SH
    Br J Clin Pharmacol; 1990 Apr; 29(4):437-45. PubMed ID: 2139339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary vascular and renal effects of cromakalim in anaesthetized dogs.
    Hicks PE; Martin D; Dumez D; Zazzi-Sudriez E; Armstrong JM
    Pflugers Arch; 1989; 414 Suppl 1():S192-3. PubMed ID: 2780259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic effects of bufuralol: a beta-adrenoceptor blocking drug with vasodilatory effects.
    Pfisterer M; Burckhardt D; Bühler FR; Burkart F
    J Cardiovasc Pharmacol; 1984; 6(3):417-22. PubMed ID: 6202966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.